Asia Pacific Personalized Medicine Market, By Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care and Personalized Nutrition and Wellness), By Application, By End-User, By Country - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Asia Pacific Personalized Medicine Market was valued at USD 98,879.23 million in 2023, expanding at a CAGR of 11.8% from 2024 to 2032.
Personalized medicine, also referred to as precision medicine, is an innovative strategy for customizing medical treatment according to the individual characteristics of each patient. This approach takes into account the variations in genes, environment, and lifestyle for every individual, enabling more accurate and effective interventions. By utilizing the unique genetic makeup of each patient, personalized medicine is gradually surpassing the limitations of traditional medical practices. It can be seen as an expansion of conventional methods in comprehending and addressing diseases. With the aid of more precise tools, physicians can now choose a therapy or treatment protocol based on a patient\'s molecular profile. This not only reduces the risk of harmful side effects and ensures a more successful outcome, but also helps in controlling costs when compared to a trial-and-error approach to disease treatment.
Asia Pacific Personalized Medicine Market- Market Dynamics
The increasing need for innovative drug development to address the growing prevalence of cancer and various diseases worldwide is anticipated to propel market expansion
Personalized medicine is centered on the creation of medications that specifically target the molecular pathways involved in the progression of diseases. This approach has the potential to result in more efficient treatments that come with fewer negative effects when compared to traditional therapies. The incidence of cancer is increasing on a global scale, and this trend is also evident in the Asia Pacific region. As a result, there is a demanding need for the development of innovative and targeted therapies that can offer more effective treatment options while minimizing side effects. According to the World Health Organization, cancer is a leading cause of death worldwide, accounting for approximately 10 million deaths in 2020, which is nearly one in six deaths. Additionally, the rapid advancements in genomics, proteomics, and bioinformatics technologies present opportunities for market growth. However, it is important to note that the complex regulatory landscape may pose restrictions on the market.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
ASIA PACIFIC PERSONALIZED MEDICINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT
Roche Diagnostics
Thermo Fisher Scientific
Qiagen
Illumina
GE Healthcare
Bio-Rad Laboratories
Agilent Technologies
Novartis AG
Pfizer Inc.
Others
ASIA PACIFIC PERSONALIZED MEDICINE MARKET, BY PRODUCT - MARKET ANALYSIS, 2019 - 2032
Personalized Medicine Diagnostics
Personalized Medicine Therapeutics
Personalized Medical Care
Personalized Nutrition and Wellness
ASIA PACIFIC PERSONALIZED MEDICINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
Oncology
CNS
Immunology
Respiratory
Others
ASIA PACIFIC PERSONALIZED MEDICINE MARKET, BY END-USER - MARKET ANALYSIS, 2019 - 2032
Hospitals
Diagnostic Centers
Research & Academic Institutes
Others
ASIA PACIFIC PERSONALIZED MEDICINE MARKET, BY COUNTRY- MARKET ANALYSIS, 2019 - 2032
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
TABLE OF CONTENT
1. Asia Pacific Personalized Medicine Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Asia Pacific Personalized Medicine Market Snippet by Product
2.1.2. Asia Pacific Personalized Medicine Market Snippet by Application
2.1.3. Asia Pacific Personalized Medicine Market Snippet by End-User
2.1.4. Asia Pacific Personalized Medicine Market Snippet by Country
2.2. Competitive Insights
3. Asia Pacific Personalized Medicine Key Market Trends
3.1. Asia Pacific Personalized Medicine Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Asia Pacific Personalized Medicine Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Asia Pacific Personalized Medicine Market Opportunities
3.4. Asia Pacific Personalized Medicine Market Future Trends
4. Asia Pacific Personalized Medicine Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Asia Pacific Personalized Medicine Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Asia Pacific Personalized Medicine Market Landscape
6.1. Asia Pacific Personalized Medicine Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Asia Pacific Personalized Medicine Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
7.1.2. Personalized Medicine Diagnostics
7.1.3. Personalized Medicine Therapeutics
7.1.4. Personalized Medical Care
7.1.5. Personalized Nutrition and Wellness
8. Asia Pacific Personalized Medicine Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
8.1.2. Oncology
8.1.3. CNS
8.1.4. Immunology
8.1.5. Respiratory
8.1.6. Others
9. Asia Pacific Personalized Medicine Market – By End-User
9.1. Overview
9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
9.1.2. Hospitals
9.1.3. Diagnostic Centers
9.1.4. Research & Academic Institutes
9.1.5. Others
10. Asia Pacific Personalized Medicine Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. Asia Pacific (APAC)
10.2.1. Overview
10.2.2. Asia Pacific Personalized Medicine Key Manufacturers in Asia Pacific
10.2.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.2.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.2.7. India
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.2.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.2.8. China
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.2.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.2.9. Japan
10.2.9.1. Overview
10.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.2.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.2.10. South Korea
10.2.10.1. Overview
10.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.2.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.2.11. Australia
10.2.11.1. Overview
10.2.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.2.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.2.12. Thailand
10.2.12.1. Overview
10.2.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.2.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.2.13. Indonesia
10.2.13.1. Overview
10.2.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.2.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.2.14. Philippines
10.2.14.1. Overview
10.2.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.14.3. Philippines
10.2.14.4. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.2.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.14.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.2.15. Rest of APAC
10.2.15.1. Overview
10.2.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.2.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Asia Pacific Personalized Medicine Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Roche Diagnostics
11.2.2. Thermo Fisher Scientific
11.2.3. Qiagen
11.2.4. Illumina
11.2.5. GE Healthcare
11.2.6. Bio-Rad Laboratories
11.2.7. Agilent Technologies
11.2.8. Novartis AG
11.2.9. Pfizer Inc.
11.2.10. Others
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
